Fusion Genomics’ SARS-CoV-2 Detection Solution Used in Pandemic Surveillance Study
Fusion Genomics has been selected to conduct a pilot study using its sequencing-based infectious...
Read MorePosted by Andy Lundin | Mar 9, 2022 | Covid 19 |
Fusion Genomics has been selected to conduct a pilot study using its sequencing-based infectious...
Read MorePosted by Andy Lundin | Mar 9, 2022 | Covid 19 |
Challenges of treating long COVID are amplified by a lack of consensus on what constitutes long COVID or how to diagnose it.
Read MorePosted by Andy Lundin | Mar 8, 2022 | Covid 19, Diagnostic Technologies |
Mask mandate laxation is concerning experts who say current testing trends won’t efficiently track the BA.2 Omicron variant as cases rise.
Read MorePosted by Andy Lundin | Mar 8, 2022 | Diagnostic Technologies, Infectious Diseases |
The diagnostic platform uses cell-free synthetic biology tools to provide rapid, de-centralized patient testing for infectious diseases.
Read MorePosted by Andy Lundin | Mar 7, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Access to the EXACT COVID-19 Antibody Test is available in the United States through AZOVA Inc, a telemedicine testing company.
Read More